SpecialtyRx Founder Joel Zupnick shares his perspective on a critical issue facing long-term care in a new article published by Life Science Daily News: medication affordability alone does not guarantee medication access.

In “Lower Drug Prices Mean Little If the Medication Can’t Reach the Resident,” Zupnick examines the complex path medications must travel from prescription to administration in skilled nursing, assisted living, and other long-term care settings. He highlights how coverage requirements, prior authorizations, medication availability, pharmacy fulfillment, delivery, and coordination among care teams can all affect whether residents receive the medications they need safely and on time.

Drawing on more than 25 years of leadership experience in long-term care pharmacy, Zupnick calls for a broader approach to drug-access reform—one that considers not only cost, but also the operational infrastructure and coordination required to get medications to residents.

‍